NO934227D0 - Pyrrolderivater, fremgangsm}te for deres fremstilling og terapeutiske anvendelse - Google Patents

Pyrrolderivater, fremgangsm}te for deres fremstilling og terapeutiske anvendelse

Info

Publication number
NO934227D0
NO934227D0 NO934227A NO934227A NO934227D0 NO 934227 D0 NO934227 D0 NO 934227D0 NO 934227 A NO934227 A NO 934227A NO 934227 A NO934227 A NO 934227A NO 934227 D0 NO934227 D0 NO 934227D0
Authority
NO
Norway
Prior art keywords
preparation
methods
therapeutic use
pyrrole derivatives
pyrrole
Prior art date
Application number
NO934227A
Other languages
English (en)
Other versions
NO934227L (no
Inventor
Mireille Sevrin
Jacques Menin
Christian Maloizel
Juan Antonio Diaz Martin
Ulpiano Martin Escudero Perez
Manuel Bedoya Zurita
Gregorio Del Sol Moreno
Maria Dolores Jimenez Bargueno
Magali Romanach Ferrer
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9214065A external-priority patent/FR2698364B1/fr
Priority claimed from FR9307538A external-priority patent/FR2706899A1/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO934227D0 publication Critical patent/NO934227D0/no
Publication of NO934227L publication Critical patent/NO934227L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO934227A 1992-11-24 1993-11-23 Pyrrolderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse NO934227L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9214065A FR2698364B1 (fr) 1992-11-24 1992-11-24 Dérivés de pyrrole, leur préparation et leur application en thérapeutique.
FR9307538A FR2706899A1 (en) 1993-06-22 1993-06-22 Pyrrole derivatives, their preparation and their therapeutic application

Publications (2)

Publication Number Publication Date
NO934227D0 true NO934227D0 (no) 1993-11-23
NO934227L NO934227L (no) 1994-05-25

Family

ID=26229898

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934227A NO934227L (no) 1992-11-24 1993-11-23 Pyrrolderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse

Country Status (16)

Country Link
US (1) US5380742A (no)
EP (1) EP0599697A1 (no)
JP (1) JPH06211869A (no)
KR (1) KR940011466A (no)
CN (1) CN1091743A (no)
AU (1) AU662846B2 (no)
CA (1) CA2109774A1 (no)
CZ (1) CZ252193A3 (no)
FI (1) FI935196A (no)
HU (1) HUT70504A (no)
IL (1) IL107726A (no)
MX (1) MX9307309A (no)
NO (1) NO934227L (no)
NZ (1) NZ250258A (no)
PL (1) PL301143A1 (no)
SK (1) SK130893A3 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719844B1 (fr) * 1994-05-10 1996-06-07 Synthelabo Dérivés de 5,6-dihydro-4h-thiéno[3,4-c]pyrrole, leur préparation et leur application en thérapeutique.
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
FR2733750B1 (fr) * 1995-05-03 1997-06-13 Synthelabo Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique
CA2327543A1 (en) * 1998-05-06 1999-11-11 Duke University Method of treating bladder and lower urinary tract syndromes
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
JP2004035507A (ja) * 2002-07-05 2004-02-05 Nippon Soda Co Ltd ピロール誘導体及びその製造方法
CN101186612B (zh) * 2006-11-15 2012-10-03 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的吡咯啉衍生物及其制备和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8529546D0 (en) * 1985-11-30 1986-01-08 Beecham Group Plc Compounds
FR2652579B1 (fr) * 1989-10-02 1992-01-24 Sanofi Sa Derives d'hydroxy-2 thiophene et furanne condenses avec un cycle azote, sur procede de preparation et leur application en therapeutique.
DE4023048A1 (de) * 1990-07-20 1992-01-23 Basf Ag Dicarbonsaeureimide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
AU664710B2 (en) * 1991-08-27 1995-11-30 Upjohn Company, The A method for treatment of metabolic disorders
US5252581A (en) * 1992-07-20 1993-10-12 Hoechst-Roussel Pharmaceuticals Inc. Substituted aminothienopyridines, pharmaceutical composition and use

Also Published As

Publication number Publication date
CN1091743A (zh) 1994-09-07
IL107726A0 (en) 1994-02-27
NZ250258A (en) 1995-07-26
AU5183193A (en) 1994-06-09
HU9303322D0 (en) 1994-03-28
SK130893A3 (en) 1994-11-09
FI935196A (fi) 1994-05-25
AU662846B2 (en) 1995-09-14
PL301143A1 (en) 1994-05-30
JPH06211869A (ja) 1994-08-02
CA2109774A1 (fr) 1994-05-25
EP0599697A1 (fr) 1994-06-01
US5380742A (en) 1995-01-10
HUT70504A (en) 1995-10-30
NO934227L (no) 1994-05-25
CZ252193A3 (en) 1994-06-15
FI935196A0 (fi) 1993-11-23
MX9307309A (es) 1994-06-30
IL107726A (en) 1997-01-10
KR940011466A (ko) 1994-06-21

Similar Documents

Publication Publication Date Title
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
NO924650D0 (no) Dialkoksy-pyridinyl-benzimidazolderivater, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse
DK0869126T3 (da) Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
NO944187D0 (no) Isokinoliner, fremgangsmåte for deres fremstilling og anvendelse
NO922275L (no) Aryletere, deres fremstilling og fremgangsmaate for behandling
NO943794D0 (no) 4-difenylmethylpiperidinderivater, og fremgangsmåte for deres fremstilling
NO955326D0 (no) Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse
NO942301D0 (no) Imidazokinazolinforbindelser og deres fremstilling og anvendelse
NO953673D0 (no) [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse
NO992676D0 (no) 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
DK317388A (da) Tricycliske pyridonderivater, deres fremstilling og anvendelse
NO962477D0 (no) Benzamidderivater, deres fremstilling og deres terapautiske anvendelse
NO940130D0 (no) Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav
NO954763D0 (no) Piperidinderivater, deres fremstilling og anvendelse
DK0835254T3 (da) Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse
NO934227D0 (no) Pyrrolderivater, fremgangsm}te for deres fremstilling og terapeutiske anvendelse
DK73091D0 (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
NO955242D0 (no) Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse
DK127288A (da) Imidazodiazepin-derivater, deres fremstilling og anvendelse
NO922992L (no) Imid-terminerte polynitrogenforbindelser, deres fremstilling og anvendelse
NO982549D0 (no) 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav
NO923249D0 (no) Terapeutisk aktive pyrimidinderivater og fremgangsmaate for deres fremstilling
NO951812D0 (no) Pyrrolderivater, deres fremstilling og anvendelse
DK193288D0 (da) Pyrrolidin-derivater, deres fremstilling og anvendelse
NO920228L (no) Polylaktider, deres fremstilling og anvendelse